The β-blocker atenolol is used widely as a first-line treatment for hypertension and as a reference drug in clinical trials. Prompted by a finding that the angiotensin-receptor blocker losartan ...

safety and cost-effectiveness as first-line treatment for hypertension. METHOD: Review of short-term comparative studies, and the outcome of long-term trials with vascular complications of ...

Hypertension, also known as high blood pressure, is the most common cardiovascular risk factor. It describes a condition ...

Patients aged 65 years and older who use acetaminophen demonstrate greater risks for serious complications, including ...

The results of this first phase 2 study of belzutifan combined with cabozantinib suggest that dual targeting of HIF-2α and VEGF pathways might be an effective first-line treatment strategy in advanced ...

Elevated blood pressure is the most important risk factor for cardiovascular disease. Numerous clinical practice guidelines ...

Idorsia Pharmaceuticals has claimed FDA approval for aprocitentan as a treatment for resistant hypertension, becoming the first drug in the endothelin receptor antagonist class for that indication.

Safety of a Potential New Treatment to Manage Complications from Sickle Cell Disease Apr. 11, 2024 — A drug approved to treat pulmonary arterial hypertension may be effective at managing ...

If you have RVD, it’s important to consider its links with hypertension. Read on to learn more about the causes, symptoms, and treatment options of this serious condition. While increased blood ...